Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-985-6 | CAS number: 901-44-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity potential of 2,2'-Isopropylidenebis(p-phenyleneoxy)diethanol was evaluated by oral route by two studies in rat. The first study considered as key (OECD 401) indicates that oral LD50 is higher than 2000 mg/kg and the second that LD50 is equal to 6400 mg/kg. The acute inhalation toxicity to rats was determined following OECD 403 at achieved concentrations of 0.021 mg/l (nominal) and no deaths or abnormalities were recorded. There was no data for dermal acute exposure.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- At the start of the main study, the males weighed 154 - 180 g, and the females 126 - 136 g, were approximately five to eight weeks old.
The animal room was maintained at a temperature of 19 - 22°C and relatve humidity of 46 - 58%. The rate of air exchange was approximately 15 changes per hour and the lighting was controlled by a time switch to give 12 hours continuous light and 12 hours darkness. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Exposure period of 14 days
- Doses:
- 2000 mg/kg bodyweight
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Preliminary study:
- A range-finding study was conducted using 1 female and 1 male rats to establish the dose regime. The dose level was 2000 mg/kg, the concentration was 200 mg/ml and the dose volume was 10 mg/kg. Overt signs or deaths were observed 30 minutes, 1, 2 and 4 hours after dosing and subsequently once daily for 5 days. There were no deaths or clinical signs of toxicity. Based on this information, a dose level of 2000 mg/kg bodyweight was selected for the main study.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was recorded.
- Clinical signs:
- other: Common signs of hunched posture were noted with additional signs of ataxia, lethargy and decreased respiratory rate. Animals recovered one day after dosing except for two males which appeared normal throughout the study.
- Gross pathology:
- No abnormalities were noted at necropsy.
- Interpretation of results:
- not classified
- Conclusions:
- The acute oral median lethal dose (LD50) of the test material in the Sprague-Dawley strain rat was found to be > 2000 mg/kg bodyweight.
- Executive summary:
The acute oral toxicity of the test substance to Sprague-Dawley rats was determined in accordance with the OECD Guideline for Testing of Chemicals 401. The rats were exposed to a dose of 2000 mg/kg bw of the test substance via oral gavage route. No mortality was observed and the acute oral median lethal dose (LD50) of the test material was found to be > 2000 mg/kg bodyweight. The test substance is not classified for acute oral toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- two acute oral toxicity studies were available and indicate the low acute toxicity of the substance.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- (Inhalation hazard test described in the Annex V; adopted 1981)
- Deviations:
- yes
- Remarks:
- not GLP study
- Principles of method if other than guideline:
- Standardized test method (BASF-Test): The test was performed in principle as described in OECD test guideline 403. It demonstrates the toxicity of an atmosphere saturated with vapours of the volatile components of a test substance at 20°C. Young adult laboratory rats, 3 per sex, were exposed sequentially to the vapours generated by bubbling 200 L/h air through a substance column of about 5 cm above a fritted glass disc in a glass cylinder for 8 h. The exposure was subsequently repeated in the same manner. No analytical determination of the atmosphere concentrations was performed. The nominal concentration was calculated as quotient of the amount of test substance weight loss during exposure, and the amount of air used during exposure. Group-wise documentation of clinical signs was performed over a 7 day study period. Body weight of groups was determined before the start of the study and at the end of the observation period.
- GLP compliance:
- no
- Test type:
- other: inhalation risk test
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
Rats were exposed for 8 h to a vapour saturated atmosphere. Vapour was generated by bubbling 200 l/h air through the liquid substance column (volume ca. 50 ml) of about 5 cm above a fritted glass disc in a glass cylinder. The air pressure was 754 mm Hg. Temperature in the exposure chamber was 20°C. Concentration was stated in the raw data to be 0.021 mg/l in the case of the 8 h exposure.
TEST ATMOSPHERE
Brief description of analytical method used: no analytics performed
Samples taken from breathing zone: no
- Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- 8 h
- Concentrations:
- No verification of the concentration was performed. Nominal concentration: 0.021 mg/L
- No. of animals per sex per dose:
- 2
- Control animals:
- no
- Details on study design:
- Duration of observation period following administration: 7 days
Frequency of observations and weighing: group wise documentation on working days
Necropsy of survivors performed: yes
Other examinations performed: clinical signs, body weight - Sex:
- male/female
- Dose descriptor:
- other: IHT
- Effect level:
- 0.021 mg/L air (nominal)
- Based on:
- test mat.
- Exp. duration:
- 8 h
- Remarks on result:
- other: No mortality.
- Mortality:
- No mortality observed.
- Clinical signs:
- other: No abnormality detected.
- Gross pathology:
- No abnormality detected.
- Interpretation of results:
- not classified
- Conclusions:
- The Inhalation Hazard Test was given as 0.021 mg/l (air). No deaths or abnormalities were recorded. The substance vapours were not toxic at the maximum achevable test concentrations.
- Executive summary:
The acute inhalation toxicity of the test substance to rats (strain not specified) was determined in accordance with the OECD Guideline for Testing of Chemicals 403. The rat was exposed to a whole body dose, nominally stated as 0.021 mg/l. The Inhalation Hazard Test was given as 0.021 mg/l (air). No deaths or abnormalities were recorded. The substance vapours were not toxic at the maximum achievable test concentrations.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 21 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Quality of whole database:
- The results of the acute inhalation study are coherent with the physico-chemical properties of the substance.
Additional information
Acute oral toxxicity :
Two acute oral toxicity studies are available with 2,2'-Isopropylidenebis(p-phenyleneoxy)diethanol.
The first study (Safepharm Laboratories Limited 1994) has been performed according to OECD 401. Five animals/sex were given 2000 mg/kg BW of 2,2'-Isopropylidenebis(p-phenyleneoxy)diethanol and observed for 14 days. No mortality was observed; common signs of toxicity (hunched posture, ataxia, lethargy and decreased respiratory rate) were noted but disappeared one day after dosing. The LD(50) was considered to be > 2000 mg/kg bw.
The second one (BASF 1970) is also based on an OECD 401 protocol but without GLP Standards.
Ten rats/sex/dose were treated by gavage at the dose-levels of 200, 1600, 3200, 4000, 5000 and 6400 mg/kg bw and observed for a 7-day period. No mortality or clinical signs were observed up to 4000 mg/kg bw.
The acute oral median lethal dose LD(50) of the test material was found to be 6400 mg/kg.
Acute inhalation toxicity :
The acute inhalation toxicity of 2,2'-Isopropylidenebis(p-phenyleneoxy)diethanol
to rats (strain not specified) was determined in accordance with the OECD Guideline for Testing of Chemicals 403. The rats (2 animals/sex) were exposed to a whole body dose, nominally stated as 0.021 mg/l. No deaths or abnormalities were recorded. The substance vapours were not toxic at the maximum achievable test concentrations.
Justification for classification or non-classification
Acute oral and inhalation toxicity studies with rats are available with 2,2'-Isopropylidenebis(p-phenyleneoxy)diethanol. No mortality was noted up to 4000 mg/kg bw by oral route or at the maximum achievable concentration of 0.021 mg/l by inhalation.
Based on these results, 2,2'-Isopropylidenebis(p-phenyleneoxy)diethanol does not have to be classified and has no obligatory labelling requirement for acute oral, inhalation and dermal toxicity according to the:
- Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2007),
- Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.